Lv1
30 积分 2022-10-14 加入
Preclinical Toxicity of AZD7969
4小时前
已完结
A novel selective estrogen receptor degrader induces cell cycle arrest in breast cancer via ERα degradation and the autophagy-lysosome pathway
1个月前
已完结
CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety
1个月前
已完结
RXR signaling targeted cancer therapy
2个月前
已完结
B-Raf inhibitor vemurafenib counteracts sulfur mustard-induced epidermal impairment through MAPK/ERK signaling
5个月前
已完结
Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies
7个月前
已完结
Diabetes mellitus: an overview of the types, symptoms, complications and management
7个月前
已完结
PKMYT1 is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer
8个月前
已完结
Adavosertib and beyond: Biomarkers, drug combination and toxicity of WEE1 inhibitors
8个月前
已完结
Recent advances in DDR (DNA damage response) inhibitors for cancer therapy
8个月前
已完结
皖公网安备34019202002308
